new glp-1 drug obesity drugs cleared of suicide warning World Health Organization recommends GLP-1

Description

doi: 10.1016/j.peptides.2019.170213

Clinically, PCOS patients exhibit reduced gut microbial -diversity, an elevated Bacteroidetes-to-Firmicutes ratio, and decreased abundance of beneficial bacteria such as Akkermansia muciniphila

Orlistat-associated adverse effects and drug interactions

Regional Analysis North America is leading the GLP-1 Receptor Agonist Market North America dominated the market with the highest revenue share of 49.7% owing to the high prevalence of both type 2 diabetes and obesity, coupled with a well-established healthcare infrastructure and favorable reimbursement policies

Chronic GLP-1 receptor activation by Exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras G12D mouse model